Delphi Genetics S.A. is a private company located in the Biopark of Gosselies (Charleroi), Belgium. It is a spinoff company from the University of Brussels (ULB).
Founded in 2001, Delphi Genetics has a proven track record in genetic engineering and bioproduction. The company develops technologies for DNA and recombinant production and it provides high quality services from development to production of plasmid DNA in GMP grade.
The company received its GMP authorization from the Federal Agency for Medicines and Health Products (FAMHP) in June 2017, and since then has supplied several batches of plasmid DNA for viral and non-viral gene therapy clinical studies. The customers of Delphi Genetics are located in Europe and USA. They are mainly biotech companies developing new gene therapies.